National Center for Rehabilitative Auditory Research (NCRAR)
ASHA and AAA CEUs will be offered for up to 1.65 CEU.
Learner Outcomes: After this conference, participants will be able to:
- Specify the prevalence of tinnitus in the population.
- Describe risk factors associated with the development of tinnitus.
- Describe at least 2 neurophysiological models of tinnitus.
- Discuss why objective measures of tinnitus do not yet exist.
- Identify at least 3 tinnitus subpopulations and the associated management implications.
- Specify the scientific evidence for the effectiveness of various established and novel interventions for tinnitus management.
NCRAR is approved by the American Academy of Audiology to offer Academy CEUs for this activity. The program is worth a maximum of 1.65 CEUs. Academy approval of this continuing education activity does not imply endorsement of course content, specific products, or clinical procedures.
Financial/Nonfinancial Relationships: Dr. Carol Bauer has a financial relationship with Sea Pharmaceuticals as an independent contractor and grant recipient; Dr. David Baguley has a financial relationship with Oticon and Otonomy as a consultant and with Auris Medical on the speaker’s bureau, as well as a non-financial professional relationship with the British Tinnitus Association as President; Dr. Mark Fagelson has a financial relationship with the Mountain Home VAMC as a consultant, and is employed by East Tennessee State University. Dr. Craig Formby has a financial relationship with NIH/NIDCD and General Hearing Instruments, Inc. as a grant recipient and independent contractor; Dr. Caroline Schmidt has a financial relationship with Desyncra as a consultant. All other speakers have no relevant financial or nonfinancial relationships to disclose.